Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DCF Combination Chemotherapy for Advanced Esophageal Cancer
NCT00915850Phase 2Unknown
- Sponsor
- Wakayama Medical University
- Start
- Aug 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in esophageal cancer, sponsored by Wakayama Medical University. Status: unknown.
02
Drugs
docetaxel
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00915850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915850.